• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, July 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Brain- and Body-First Subtypes Identified in Lewy Body Disease

Bioengineer by Bioengineer
July 17, 2026
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new review in Nature Reviews Neurology argues that the striking variability of Lewy body disease—ranging from fluctuating symptoms to different patterns of neurodegeneration on brain scans—may be explained by a “brain-first versus body-first” (BvB) framework. Rather than treating Lewy pathology as a single, uniform process, the authors propose that it can originate in fundamentally different peripheral or central sites, leading to distinct clinical trajectories.

In the BvB model, Lewy pathology may begin either in autonomic nerves serving the gut and other peripheral neurons (“body first”) or in the olfactory bulb, from which it spreads into limbic circuits (“brain first”). In both routes, the earliest steps are thought to occur largely outside the central nervous system, potentially after exposure to external triggers such as infectious agents or toxins.

The review highlights how timing differences in early symptoms can map onto these pathways. Some people develop autonomic dysfunction and sleep disturbances years before a formal diagnosis, whereas others show these features only after clinical onset—suggesting non-identical underlying origins.

A key technical observation concerns neurodegeneration sequence. Among individuals with prodromal sleep disorders, cardiac sympathetic denervation reportedly appears about a decade before nigrostriatal degeneration. In contrast, in those lacking such sleep prodromes, the order of degeneration is reversed, aligning with the idea that pathology may start in different anatomical “entry points.”

Pathology gradients at post-mortem also support the model. Studies frequently report either bottom-up patterns consistent with peripheral initiation (“body first”) or top-down patterns consistent with an olfactory-first route (“brain first”), implying that spread follows anatomy-dependent routes rather than a single linear cascade.

The review critically evaluates these findings while acknowledging limitations, including variability in how prodromal symptoms are recorded and differences across imaging and pathology methods. It also emphasizes that not all cases may fit neatly into two categories, and mixed or intermediate patterns could occur.

Beyond explaining heterogeneity, the BvB framework could reshape diagnostics. It points toward stratifying patients based on early autonomic and sleep signatures, and toward imaging or biomarker strategies that reflect the expected temporal order of neuronal loss in each subtype.

Therapeutic implications are equally important: interventions aimed at early peripheral processes might benefit body-first patients differently than strategies targeting central spread would for brain-first patients. Preventive approaches could likewise leverage the model’s hypothesis of exogenous triggers that initiate pathology before CNS involvement becomes detectable.

Finally, the authors outline future research directions, including tighter longitudinal studies linking peripheral biomarkers, imaging, and post-mortem patterns in larger cohorts. If validated, the BvB model could become a practical blueprint for translating mechanistic diversity into precision medicine for Lewy body disease.

Subject of Research: Lewy body disease subtypes; brain-first vs body-first progression model

Article Title: Brain-first and body-first subtypes of Lewy body disease.

Article References: Borghammer, P., Van Den Berge, N., Berg, D. et al. Brain-first and body-first subtypes of Lewy body disease. Nat Rev Neurol (2026). https://doi.org/10.1038/s41582-026-01241-8

Image Credits: AI Generated

DOI: 10.1038/s41582-026-01241-8

Keywords: Lewy body disease, brain-first, body-first, prodromal sleep disorders, autonomic dysfunction, olfactory bulb, cardiac sympathetic denervation, nigrostriatal degeneration

Tags: autonomic dysfunction in Lewy body diseasebrain-first versus body-first subtypesearly clinical symptoms in Lewy body diseaseheterogeneity of Lewy body disease clinical trajectoriesinfectious triggers and toxins in Lewy disease developmentLewy body diseaseneurodegeneration pathways in Lewy pathologyneurodegenerativeneuroimaging patterns in Lewy body diseaseolfactory bulb involvement in Lewy pathologyperipheral versus central origins of Lewy diseaseprogression of sleep disturbances in Lewy pathology

Share12Tweet7Share2ShareShareShare1

Related Posts

Purpose in life predicts well-being and capabilities in older Thai adults

July 17, 2026

Synthetic nanoassemblies restore disrupted intracellular homeostasis

July 17, 2026

Study Finds Some Medical Spas Sell Compounded Weight-Loss Drugs Despite Regulatory Worries

July 17, 2026

Rethinking Cardiometabolic Treatment Thresholds for People Living With Obesity

July 17, 2026

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Scalable Shear-Exfoliated Graphene Enables High-Performance Low-Carbon Recycled Concrete

Purpose in life predicts well-being and capabilities in older Thai adults

Brain- and Body-First Subtypes Identified in Lewy Body Disease

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.